SG Americas Securities
MRNA icon

SG Americas Securities’s Moderna MRNA Stock Holding History

SG Americas Securities’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$467K Sell
20,900
-150,000
-88% -$7M ﹤0.01% 2221
2025
Q4 		$148K Buy
170,900
+150,000
+718% +$4.08M ﹤0.01% 3050
2025
Q3 		$107K Buy
+20,900
New +$583K ﹤0.01% 3054
2024
Q4 		– Sell
-11,700
Closed -$21K – 3430
2024
Q3 		$21K Sell
11,700
-39,100
-77% -$3.59M ﹤0.01% 3342
2024
Q2 		$532K Sell
50,800
-8,200
-14% -$1.04M ﹤0.01% 1650
2024
Q1 		$446K Sell
59,000
-9,000
-13% -$907K ﹤0.01% 1487
2023
Q4 		$329K Buy
68,000
+7,500
+12% +$631K ﹤0.01% 1757
2023
Q3 		$456K Buy
60,500
+20,900
+53% +$2.33M 0.01% 1830
2023
Q2 		$495K Buy
39,600
+25,500
+181% +$3.4M ﹤0.01% 1394
2023
Q1 		$247K Sell
14,100
-84,800
-86% -$14M ﹤0.01% 2269
2022
Q4 		$629K Sell
98,900
-135,000
-58% -$22.1M 0.01% 1343
2022
Q3 		$315K Buy
233,900
+215,000
+1,138% +$32.6M ﹤0.01% 1946
2022
Q2 		$111K Sell
18,900
-25,000
-57% -$3.57M ﹤0.01% 3063
2022
Q1 		$703K Buy
43,900
+8,700
+25% +$1.46M 0.01% 1667
2021
Q4 		$361K Sell
35,200
-159,800
-82% -$46.7M ﹤0.01% 2344
2021
Q3 		$1.03M Buy
195,000
+165,000
+550% +$60.9M ﹤0.01% 1880
2021
Q2 		$1.87M Buy
+30,000
New +$5.36M 0.01% 1171

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SG Americas Securities's MRNA Position: Q1 2026 in Review

SG Americas Securities reduced its Moderna (MRNA) stake by 10% in Q1 2026, selling an estimated $1.3M and leaving 250,868 shares worth $12.7M. The position accounts for 0.01% of the portfolio, ranked #704.

SG Americas Securities first reported a position in MRNA in Q2 2020 and has held it in 24 quarters since. The position peaked at $34.4M in Q1 2022. 722 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

  • SG Americas Securities held 250,868 shares of Moderna worth $12.7M as of Q1 2026.
  • SG Americas Securities sold 27,930 Moderna shares in Q1 2026, an estimated $1.3M.
  • Moderna made up 0.01% of SG Americas Securities's portfolio in Q1 2026, its #704 holding.
  • SG Americas Securities first reported a position in Moderna in Q2 2020 and has held it in 24 quarters since.
  • SG Americas Securities's Moderna position peaked at $34.4M in Q1 2022.
  • 722 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on SG Americas Securities's 13F filing for Q1 2026, filed 16 Apr 2026.